Sanofi Consumer Healthcare India
NSE: SANOFICONR · ISIN INE0UOS01011 · Healthcare
₹3,415.40−81.30 (−2.33%)
Monday 9 November, 13:29 IST. Delayed. Source: Yahoo Finance.
Price chart
₹3,415.40 −81.30 (−2.33%) today
The day
- Previous close
- ₹3,496.70
- Open
- ₹3,496.60
- Day high
- ₹3,496.70
- Day low
- ₹3,396.10
Listed on NSE since 13 September 2024.
Key numbers
- Market value
- ₹7,877.10 Cr
- P/E (trailing)
- 28.75
- EPS (trailing)
- ₹118.78
- Price to book
- 22.61
- Dividend yield
- 2.14%
- Debt to equity
- 0.06
- Profit margin
- 28.6%
- Beta
- 0.34
- Volume today
- 3,069
- Average volume
- 16,351
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| Year to December 2023 | ₹544.30 Cr | ₹164.90 Cr |
| Year to December 2024 | ₹716.20 Cr | ₹181.00 Cr |
| Year to December 2025 | ₹878.00 Cr | ₹240.10 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹263 Cr | ₹77 Cr | +21.8% |
| Q1 FY27Apr–Jun 2026 | ₹236 Cr | ₹69 Cr | +13.3% |
| Q4 FY26Jan–Mar 2026 | ₹229 Cr | ₹68 Cr | +35.6% |
| Q3 FY26Oct–Dec 2025 | ₹251 Cr | ₹67 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹234 Cr | ₹63 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹221 Cr | ₹61 Cr | – |
Source: Sanofi Consumer Healthcare India’s results filed with NSE, standalone (the company alone). Net profit is the share of Sanofi Consumer Healthcare India’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | June 2026 | December 2025 |
|---|---|---|
| Fixed assets | ₹30 Cr | ₹35 Cr |
| Inventories | ₹94 Cr | ₹62 Cr |
| Owed by customers | ₹50 Cr | ₹30 Cr |
| Cash and equivalents | ₹490 Cr | ₹375 Cr |
| Total assets | ₹706 Cr | ₹547 Cr |
| Borrowings | ₹0 | ₹0 |
| Total liabilities | ₹359 Cr | ₹163 Cr |
| Shareholders’ equity | ₹348 Cr | ₹384 Cr |
Source: Sanofi Consumer Healthcare India’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Opella Healthcare Participations B.V.
- Industry
- Drug Manufacturers - General
- Based in
- Mumbai
- Employees
- 597
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Sanofi Consumer Healthcare India in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 75 Per Share
Dividend · ex-date 19 June 2026
- Dividend - Rs 55 Per Share
Dividend · ex-date 17 April 2025
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.